Timi score aspirin11/21/2023 To know the correlation of clinical risk scores with angiographic extent of coronary artery disease. New risk stratification tools for patients with type 2 MI could guide risk-based monitoring and post-discharge care and improve patient categorization for clinical trials.The correlation of clinical risk predictors and clinical risk scores: Thrombolysis in Myocardial Infarction (TIMI), Platelet Glycoprotein IIb-IIIa in Unstable Angina, Receptor Suppression Using Integrilin Therapy (PURSUIT) and Global Registry of Acute Coronary Events (GRACE) scores in Unstable Angina with angiographic extent of Coronary Artery Disease (CAD) is not known. In this study cohort, only 1.7% of patients underwent revascularization, and the use of secondary prevention medications was relatively low (aspirin, 69% P2Y12 inhibitors, 11% statins, 71% beta blockers, 65%). The limited value of the GRACE and TIMI scores in patients with type 2 MI might be attributable to the fact that such patients tend to be older and have a greater comorbidity burden than the type 1 MI cohorts from which the scores were derived.Īnother problem might be the less frequent use of traditional type 1 MI therapies by patients with type 2 MI. ![]() MACE (a composite of cardiovascular mortality, stroke and recurrent type 1 or type 2 MI): The TIMI score modestly predicted 30-day MACE but not MACE in-hospital or at 90 days the GRACE and TARRACO scores did not predict MACE.Cardiovascular Mortality: The TIMI and GRACE scores were modestly predictive the TARRACO score was not predictive. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |